Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration

Sara Nysom  Christiansen; Lykke Midtbøll Ørnbjerg; Simon Horskjær Rasmussen; AG Loft; Merete Lund Hetland; Mikkel Østergaard

Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration

Sara Nysom Christiansen, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, AG Loft, Merete Lund Hetland, Mikkel Østergaard

Department for Rheumatology and Spine Diseases

Original language	English
Article number	OP0220
Journal	Annals of the Rheumatic Diseases
Volume	80
Issue number	Supplement 1
Pages (from-to)	131-2
Number of pages	2
ISSN	0003-4967
Publication status	Published - 2021

Cite this

Christiansen, S. N., Ørnbjerg, L. M., Rasmussen, S. H., Loft, AG., Hetland, M. L., & Østergaard, M. (2021). Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. Annals of the Rheumatic Diseases, 80(Supplement 1), 131-2. Article OP0220.

Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. / Christiansen, Sara Nysom ; Ørnbjerg, Lykke Midtbøll; Rasmussen, Simon Horskjær et al.
In: Annals of the Rheumatic Diseases, Vol. 80, No. Supplement 1, OP0220, 2021, p. 131-2.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Christiansen, SN , Ørnbjerg, LM, Rasmussen, SH, Loft, AG, Hetland, ML & Østergaard, M 2021, 'Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration', Annals of the Rheumatic Diseases, vol. 80, no. Supplement 1, OP0220, pp. 131-2.

Christiansen, Sara Nysom ; Ørnbjerg, Lykke Midtbøll ; Rasmussen, Simon Horskjær et al. / Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. In: Annals of the Rheumatic Diseases. 2021 ; Vol. 80, No. Supplement 1. pp. 131-2.

@article{f5c93152c5d2469b94024e5d7334f792,

title = "Secular trends in baseline characteristics, treatment retention and response rates in 17,453 biona{\"i}ve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration",

author = "Christiansen, {Sara Nysom} and {\O}rnbjerg, {Lykke Midtb{\o}ll} and Rasmussen, {Simon Horskj{\ae}r} and AG Loft and Hetland, {Merete Lund} and Mikkel {\O}stergaard",

note = "COPECARE",

year = "2021",

language = "English",

volume = "80",

pages = "131--2",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Supplement 1",

}

TY - ABST

T1 - Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration

AU - Christiansen, Sara Nysom

AU - Ørnbjerg, Lykke Midtbøll

AU - Rasmussen, Simon Horskjær

AU - Loft, AG

AU - Hetland, Merete Lund

AU - Østergaard, Mikkel

N1 - COPECARE

PY - 2021

Y1 - 2021

M3 - Conference abstract in journal

SN - 0003-4967

VL - 80

SP - 131

EP - 132

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Supplement 1

M1 - OP0220

ER -